Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0869-2023

Drug recall · June 14, 2023

Buprenorphine Sublingual Tablets recall

Why: CGMP Deviations

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Buprenorphine Sublingual Tablets, 8 mg, 30 count-bottles, Rx only, Manufactured by: Sun Pharma, NDC 62756-460-83.

Lots / codes

Lot #: DND1515A, Exp 08/24

Quantity
12,336 bottles
Company
Sun Pharmaceutical Industries Inc, Princeton, NJ
Distribution
Product was distributed to 19 distributors nationwide.
Initiated
May 3, 2023 · Voluntary: Firm initiated
Classified
June 7, 2023
Reported
June 14, 2023
Ended
January 9, 2024
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Buprenorphine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.